|
Investigation On Behalf of Shareholders of AtriCure, Inc Announced |
|
|
|
|
Written by Globe NewsWire
|
|
Tuesday, 04 November 2008 |
|
Bensalem, Pennsylvania - Law Offices of Howard G. Smith announces that it is investigating potential claims against AtriCure, Inc. ("AtriCure" or the "Company") (Nasdaq:ATRC) concerning possible securities violations in relation to public statements made by the Company between May 10, 2007 and October 31, 2008.
The investigation focuses on the Company's October 31, 2008, press release in which AtriCure disclosed that it had received a letter from the U.S. Department of Justice-Civil Division (the "DOJ") informing the Company that the DOJ is conducting an investigation of potential False Claims Act and common-law violations relating to the Company's surgical ablation devices. According to AtriCure, the DOJ is investigating the Company's marketing practices utilized in connection with AtriCure's surgical ablation system to treat atrial fibrillation, a specific use outside the Federal Food and Drug Administration's 510(k) clearance. The Company further disclosed that the DOJ is investigating whether AtriCure instructed hospitals to bill Medicare for surgical ablation using incorrect billing codes.
If you have information or if you purchased AtriCure common stock during the period stated above and would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
|
